A new Canadian study agrees with the well-established link between Actos and bladder cancer.
The study, published in the Canadian Medical Association Journal, was conducted via meta-analysis, meaning it sought patterns in data compiled by numerous other studies. The study examined the relationship between diabetes medications known as thiazolidinediones and bladder cancer.
It explored data from 10 different studies that included more than 2.5 million patients. It concluded that Actos increased the risk of bladder cancer by 22 percent.
Actos has been linked to many dangerous conditions. If you or someone you care for has taken Actos and been diagnosed with bladder cancer, you may be eligible for compensation from the drug’s manufacturer. Contact the Actos lawsuit attorneys of Williams Kherkher at 800-641-9810 to learn more.